Sami Inkinen founded and then exited Trulia about a year after Zillow snapped it up for $3.5 billion in 2014. Hes since moved on to build Virta, a health care startup claiming it can cure type 2 diabetes.
Its a bold claim. Most treatment plans offer to help those with the disease manage it, not get rid of it. But Inkinen, with zero medical background, believes hes found a way to wholly eradicate diabetes for good.
The secret is as simple as a low-carb diet.
It seems pretty obvious cut out the sugar and bad carbs and your diabetes will get better. But thats easier said than done with humans. Inkinen tells me hes learned through time where the pain points are and what people need to truly succeed.
So far Virta has conducted a small trial involving 262 people and the results seem promising. A majority (91 percent) of those participating finished the program and 87 percent of them either reduced their dosage or went off their insulin, says the startup. Over half of the participants were able to reduce at least one of their diabetes medications.
I sat down with Inkinen to talk about his company and why he decided to jump into the health care space after his success in the real estate field.
Founder Sami Inkinen relaxing in the Virta office space in downtown San Francisco.
SB: Thats a bold claim that youre making that you can cure diabetes.
SI: Yeah totallyWithout tech you cant do Virta.
Were not just a software company, were a software company that combines biochemistry and science to cure the disease. If one of those is wrong its not going to work.
SB: Do you worry you tell them a bit too early to get off their medications?
SI: Yeah, thats precisely the reason why we have our own doctors. Thats precisely the reason why we have a full-stack health care companyIts absolutely critical that we get this data very, very rapidly so we can start adjusting them off of meds. If we dont get people off the meds quickly and accurately, its actually dangerous for the patients. When youre diabetic your blood sugar runs high. You take drugs, you get it down. If we can get your blood sugar down naturally and then you take drugs on top of that youre going to be in the ER.
SB: Insurance companies, are you working with them?
SI: Well, they are excited because they can save costs. In America, each state we have who pays your health care. Its either your employer if youre at a large company, and most companies will cover it. So we sell both to employers.
SB: Okay, but this just sounds like a diet.
SI:It sounds very simple. Like, oh carbs are bad throw the carbs out. Yes, but it gets more nuanced. How do you do it in a way that you can reverse the type 2 diabetes and do it in a way thats very sustainable and you feel good about it? Because you know if youre eating bagels and bread all the time and I say just stop doing that, you feel horrible and you dont want to do that.
Its absolutely necessary to deliver results. The traditional approach is that its overweight or obesity that causes diabetes. Therefore all we have to do is help people lose weight. But, its a combination of tech and how we track the markers and the right science nutritionally.
SB: Is that proprietary software that youre using?
SI: Yeah, we build everything in house After the doctor makes all the clinical decisions about the patient, and so forth, what hes looking at is basically a data pool of all the patients every day, several times a day. When he sees the data, he sees that drug for that patient needs to go off.
SB: Couldnt anyone look at it and say, Oh, I can replicate this program?
SI: Well it has the IP. The IP is in two places. One is the protocol that we use, which drives high participation and the results. Its not trivial. It really has to be highly individualized. Whether its food or what you do or how you choose medications, its nothing one-size fits all. Every person is different. Thats the first one.
The second one is this entire system where we collect data and data improves the protocols, this kind of cycle. The more data we have the better the protocol, the better the treatment, the more we can automate, the more efficient we can be.
The way we use software and AI for the benefit of doctors is we basically give them superpowers. We can read all that data on a real-time basis every day of every second and then tell our patients, Okay, Wilma she needs attention. Her, whatever medication she might be on, needs to be reduced.
SB: How do you do that?
SI: What we try to do is take thinking out of the picture for the patients. Every morning that you wake up you have a task to complete. Whether thats tracking related, changing your nutrition, or some behavior change, or something else. We basically stitch together a personalized care plan for each patient based on whats their background and whats happening to them.
You may have heard the Center for Disease Control, CDC, has a diabetes prevention program, which is really a weight loss program. Its basically 16 educational modules over 16 weeksIts kind of like the diet approach, the cookie-cutter approach. You want to do the South Beach Diet, buy the South Beach Diet book and you get the 50 foods that we should eat and the 50 foods you shouldnt.
You cant be successful in curing someones health if you have a one-size fits all approach.
SB: You got involved because you were pre-diabetic.
SI: I was on my way, yes. I was pre-diabetic. You may remember, Ive got a company called Trulia, which just happens to be in this building. Once Trulia went public, I just stayed on the board and I stepped away from an operational role.
I thought maybe Ill start competing and I won the Ironman World Championships in my age group.
(Inkinen has been a competitive triathlete since 2007).
SB: Really?
SI: I was like wow, this is freaking awesome. Then I found out that I was pre-diabetic.
SB: Even after you were very active and athletic?
SI: That was my moment of truth, if you will. I thought, it doesnt make any sense. What we are telling people to do, the message to pre-diabetics today in America is Dont you worry. Youre getting fit but you have to eat a little less, eat a little healthier and exercise a little more everything will be just fine. Well I had been doing that freaking 20 years.
SB: Mm-hmm.
SI:That was the turning point for me. I started reading research and thats what kind of led me to meet my scientific co-founders. The bottom line, what these guys had shown is that there is a way to nutritionally reverse type 2 diabetes without starving you to death. They had published all these papers. I was like this is nuts. This is 30 years-old science.
I said the key thats missing here is we dont have the tech to deliver this, the continuous outpatient services. That was the catalyst for Virta.
Then we kind of built the protocol, built the first product, and then the key step for me was I said we dont want to be another Theranos. In health care, maybe were just shrinking our own pool, but we have to run a clinical trial. If this works, this is going to be absolutely huge.
SB: If an employer wants to get involved with your program, do they just contact you?
SI: Call us up, through our website, and also of course we have our sales as wellOur business model is, if we dont reverse diabetes we dont want to be paid.
SB:When youre saying that you cure it, do you mean that if they switch back to the same old diet they wouldnt have diabetes?
SI: Well type two diabetes is not an acute, like broken bones and then the bone is fixed and then its not broken anymore.
Type 2 diabetes can be reproduced in any one patient. Of course, the subtle lifestyle changes have to last and thats why you want to show that once you cure the disease it actually stays in remission.
SB: Whats the individual cost?
SI:Its about $400 a month. Then low-income people we have patients that use a program that keeps them with access.
SB: So, if the drugs are $500 and this is $400
SI: Yeah so thats the average cost of diabetic medicine in America.
SB: Do they have to stay on the program for life? $400 a month for life?
SI: Its one year minimum and then the second year is up to your choice. Whether you need our support or not.
SB: Whats next?
SI: Theres a couple of big things coming out. One is the one-year results (now out at the time of publishing). Thats one huge thing for usWe can make powerful claims like Hey, the reversal rate is this much, how much we saved money, this is how many lives we saved. These are the results.
Then the second thing that were focused on is just scaling with employers, insurance companies, and patients directly. Letting them know that this works.
Continued here:
Sami Inkinen on his bold plan to cure type 2 diabetes forever ... - TechCrunch
- Whats Next in Diabetes Care: Innovations and Insights - Beyond Type 1 - April 14th, 2025
- Common Additive Combos in Food And Drinks May Raise Risk of Type 2 Diabetes - ScienceAlert - April 14th, 2025
- Explained: What is Type-5 diabetes? Why the malnutrition-induced condition is back? - Sambad English - April 14th, 2025
- A comprehensive review on the implications of Yogic/ Sattvic diet in reducing inflammation in type 2 diabetes - Nature - April 14th, 2025
- These Food Additives Could Increase Your Risk of Diabetes - VICE - April 14th, 2025
- How Common Food Additives are Linked to Type-2 Diabetes - Discover Magazine - April 14th, 2025
- A conversation about living with Pompe disease and diabetes - Pompe Disease News - April 14th, 2025
- Diabetes in pregnant mothers linked to ADHD and autism risk in children - The Independent - April 14th, 2025
- Study explores potential increased risk between diabetes during pregnancy and ADHD, autism - CBS News - April 14th, 2025
- Possible link between eating food additives and diabetes - KSNV - April 14th, 2025
- GLP-1s Eyed as Key to Managing T1D With Obesity - Medscape - April 14th, 2025
- Want to Lower Your Diabetes Risk? This Kind of Exercise Could Help, Recent Study Says - EatingWell - April 14th, 2025
- Cdk5 inhibitor shows anti-diabetic and neuroprotective effects in type 2 diabetes - BioWorld MedTech - April 14th, 2025
- Researchers uncover a link to autismand it isnt vaccines - Fortune - April 14th, 2025
- Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System - Dexcom - April 14th, 2025
- Heart of the Valley: Hidalgo County man managing his diabetes after losing 60 pounds - KRGV - April 14th, 2025
- Tandem Diabetes Care (TNDM) Moves 7.6% Higher: Will This Strength Last? - Yahoo Finance - April 14th, 2025
- FGCU Beach Volleyball's Jaci Carpenter not allowing Type 1 diabetes to get in the way - WBBH - April 14th, 2025
- Biomarkers of Inflammation, Oxidative Stress, and Endothelial Dysfunction in Early Detection of Diabetic Foot Ulcers - Cureus - April 14th, 2025
- Unstable Blood Sugar Levels Tied to Higher Erectile Dysfunction Risk in Men with Type 2 Diabetes: Study - Medical Dialogues - April 14th, 2025
- This 'itchy' symptom is an early sign of diabetes that people often miss; know more about it - The Times of India - February 7th, 2025
- Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024 - ABC News - February 7th, 2025
- Incidence of type 2 diabetes and metabolic syndrome by Occupation 10-Year follow-up of the Gutenberg Health Study - BMC Public Health - February 7th, 2025
- Abbotts Above the Bias Film Reveals Misconceptions Can Impact Diabetes Care - MultiVu - February 7th, 2025
- Q&A: Diabetes care for the aging population in the digital age - Medical Xpress - February 7th, 2025
- The relationship between oxLDL, sLOX-1, PCSK9 and carotid intima-media thickness in patients with prediabetes and type 2 diabetes - Nature.com - February 7th, 2025
- Nanoparticle Therapy has Potential to Reprogram the Immune System in Type 1 Diabetes - Managed Healthcare Executive - February 7th, 2025
- Muscle quality index is correlated with insulin resistance and type 2 diabetes mellitus: a cross-sectional population-based study - BMC Public Health - February 7th, 2025
- Assessing type-2 diabetes risk based on the Indian diabetes risk score among adults aged 45 and above in India - Nature.com - February 7th, 2025
- Single-cell atlas of human pancreatic islet and acinar endothelial cells in health and diabetes - Nature.com - February 7th, 2025
- Sugary Drinks Fuel Millions of Diabetes and CVD Cases - Medscape - February 7th, 2025
- 1 in 5 UK adults estimated to have diabetes in new record high - Euronews - February 7th, 2025
- New, increasingly widely used diabetes medication may have additional health benefits for older adults - Medical Xpress - February 7th, 2025
- Patients using diabetes apps can miss critical alerts. Heres how to make sure youre getting them - Canon City Daily Record - February 7th, 2025
- Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024 - News-Press Now - February 7th, 2025
- Does wearing a continuous glucose monitor help people without diabetes? We asked experts. - Popular Science - February 7th, 2025
- What is prediabetes and what can you do to stop it? - The Independent - February 7th, 2025
- Diabetes symptoms: 6 high blood sugar warning signs that show on hand and feet - India.com - February 7th, 2025
- The #1 Habit for Better Heart Health If You Have Diabetes, According to Experts - EatingWell - February 7th, 2025
- 'Fix Broken Food System!' Government Urged as Study Says 1 in 5 Brits Affected by Diabetes - Men's Health UK - February 7th, 2025
- World Diabetes Day 2024 - World Health Organization (WHO) - December 6th, 2024
- The WHO Global Diabetes Compact - December 6th, 2024
- Diabetes - World Health Organization (WHO) - December 6th, 2024
- Kumamoto University researchers discover groundbreaking antidiabetic compound - EurekAlert - December 6th, 2024
- Med's David Kaelber comments on GLP-1 agonists, which provide benefits like managing diabetes and weight loss - The Daily | Case Western Reserve... - December 6th, 2024
- Jordan Chiles Is On a Mission To Raise Awareness for Early Type 1 Diabetes Screening - Verywell Health - December 6th, 2024
- There's A Tasty Food That May Reduce Your Risk Of Developing Type 2 Diabetes, Study Shows - HuffPost - December 6th, 2024
- Empagliflozin Linked to Lower Risk of Diabetic Retinopathy Progression - Medpage Today - December 6th, 2024
- GLP-1 Medications Associated with Reduced Likelihood of Dementia Compared to Other Diabetic Meds - Epic Research - December 6th, 2024
- Sanders Slams Greed That Led to Surge in Obesity, Diabetes in US - The Well News - December 6th, 2024
- Eli Lilly to Expand Facility to Meet Demand for Diabetes, Obesity Treatments - The Wall Street Journal - December 6th, 2024
- New Study Teases Out Chocolate and Diabetes Connection - Medpage Today - December 6th, 2024
- Diabetes tool turned wellness trend: Is a glucose monitor right for you? - KARE11.com - December 6th, 2024
- Reporter doesnt have diabetes but wore a glucose monitor anyway. Here's what she learned - CNN - December 6th, 2024
- Lilly's Zepbound (tirzepatide) superior to Wegovy (semaglutide) in head-to-head trial showing an average weight loss of 20.2% vs. 13.7% - Investors |... - December 6th, 2024
- I dont have diabetes, but I wore a glucose monitor for six weeks. Heres what I learned about food (and anxiety) - CNN - December 6th, 2024
- Higher niacin levels linked to lower cardiovascular risk, but not in those with diabetes - Healio - December 6th, 2024
- This Type Of Chocolate Could Reduce Type 2 Diabetes Risk By 21% - NDTV - December 6th, 2024
- New Study Links Safer BPA Alternatives to Obesity, Diabetes, and Hormone Disruption - SciTechDaily - December 6th, 2024
- Turns Out Dark Chocolate Has a Health Benefit That's Shockingly GreatAnd Totally Unexpected - Well+Good - December 6th, 2024
- Global report on diabetes - World Health Organization (WHO) - October 22nd, 2024
- Ultra-processed food may be particularly harmful for people with diabetes, scientists warn - The Independent - October 22nd, 2024
- New drugs may be able to treat multiple problems beyond diabetes - The Straits Times - October 22nd, 2024
- Best Fruits for Diabetes (and What To Avoid) - Health Essentials - October 22nd, 2024
- Cutting Sugar May Reduce Your Diabetes, Stroke, and Depression Risk - Healthline - October 22nd, 2024
- Can Diabetes Care Teams Improve Patient Outcomes and Value? - Medscape - October 22nd, 2024
- Oral Semaglutide Reduces MACE Risk in People With Type 2 Diabetes and CVD - MD Magazine - October 22nd, 2024
- High expression of CNOT6L contributes to the negative development of type 2 diabetes - Nature.com - October 22nd, 2024
- Recent Advances and Therapeutic Benefits of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Management of Type 2 Diabetes and Associated Metabolic... - October 22nd, 2024
- Dental teams could detect undiagnosed diabetes in more than one million people with new care pathway - Nature.com - October 22nd, 2024
- Groundbreaking Innovations in Diabetes Care: Highlights from the 2024 Diabetes Technology Meeting - Beyond Type 1 - October 22nd, 2024
- COVID-19 linked to type 2 diabetes onset in children - Medical Xpress - October 22nd, 2024
- The effect of adding pancreatin to standard otilinium bromide and simethicone treatment in type 2 diabetes mellitus patients with irritable bowel... - October 22nd, 2024
- Does microdosing Ozempic work? What experts are saying about the diabetes drug also used for weight loss - Medical Xpress - October 22nd, 2024
- The Link between GLP-1 Drugs and Diabetic Retinopathy Is Not So Clear | AAO 2024 - Managed Healthcare Executive - October 22nd, 2024
- The overexpression of human amylin in pancreatic cells facilitate the appearance of amylin aggregates in the kidney contributing to diabetic... - October 22nd, 2024
- RNAO releases updated guidelines for diabetic foot ulcer care - Benefits and Pensions Monitor - October 22nd, 2024
- COVID-19 raises the risk of type 2 diabetes in children, study reveals - News-Medical.Net - October 22nd, 2024
- Semaglutide: What impact does it really have on heart health? - Medical News Today - October 22nd, 2024
- Glucose monitors for diabetes have finally been funded but a chronic workforce shortage will limit the benefits - The Conversation - October 22nd, 2024